574 related articles for article (PubMed ID: 34074214)
1. Engraftment of strictly anaerobic oxygen-sensitive bacteria in irritable bowel syndrome patients following fecal microbiota transplantation does not improve symptoms.
Browne PD; Cold F; Petersen AM; Halkjær SI; Christensen AH; Günther S; Hestbjerg Hansen L
Gut Microbes; 2021; 13(1):1-16. PubMed ID: 34074214
[TBL] [Abstract][Full Text] [Related]
2. Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D.
Singh P; Alm EJ; Kelley JM; Cheng V; Smith M; Kassam Z; Nee J; Iturrino J; Lembo A
Gut Microbes; 2022; 14(1):2020067. PubMed ID: 35014601
[TBL] [Abstract][Full Text] [Related]
3. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study.
Halkjær SI; Christensen AH; Lo BZS; Browne PD; Günther S; Hansen LH; Petersen AM
Gut; 2018 Dec; 67(12):2107-2115. PubMed ID: 29980607
[TBL] [Abstract][Full Text] [Related]
4. Effects of fecal microbiota transplantation in subjects with irritable bowel syndrome are mirrored by changes in gut microbiome.
Goll R; Johnsen PH; Hjerde E; Diab J; Valle PC; Hilpusch F; Cavanagh JP
Gut Microbes; 2020 Nov; 12(1):1794263. PubMed ID: 32991818
[TBL] [Abstract][Full Text] [Related]
5. Relief of irritable bowel syndrome by fecal microbiota transplantation is associated with changes in diversity and composition of the gut microbiota.
Huang HL; Chen HT; Luo QL; Xu HM; He J; Li YQ; Zhou YL; Yao F; Nie YQ; Zhou YJ
J Dig Dis; 2019 Aug; 20(8):401-408. PubMed ID: 31070838
[TBL] [Abstract][Full Text] [Related]
6. The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation.
Mazzawi T; Lied GA; Sangnes DA; El-Salhy M; Hov JR; Gilja OH; Hatlebakk JG; Hausken T
PLoS One; 2018; 13(11):e0194904. PubMed ID: 30427836
[TBL] [Abstract][Full Text] [Related]
7. Fecal microbiota transplantation in patients with irritable bowel syndrome: an overview of current studies.
Körner E; Lorentz A
J Appl Microbiol; 2023 Mar; 134(3):. PubMed ID: 36882216
[TBL] [Abstract][Full Text] [Related]
8. Recipient microbiome-related features predicting metabolic improvement following fecal microbiota transplantation in adults with severe obesity and metabolic syndrome: a secondary analysis of a phase 2 clinical trial.
Zhang Z; Mocanu V; Deehan EC; Hotte N; Zhu Y; Wei S; Kao DH; Karmali S; Birch DW; Walter J; Madsen KL
Gut Microbes; 2024; 16(1):2345134. PubMed ID: 38685731
[TBL] [Abstract][Full Text] [Related]
9. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial.
Holvoet T; Joossens M; Vázquez-Castellanos JF; Christiaens E; Heyerick L; Boelens J; Verhasselt B; van Vlierberghe H; De Vos M; Raes J; De Looze D
Gastroenterology; 2021 Jan; 160(1):145-157.e8. PubMed ID: 32681922
[TBL] [Abstract][Full Text] [Related]
10. Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.
Mizuno S; Masaoka T; Naganuma M; Kishimoto T; Kitazawa M; Kurokawa S; Nakashima M; Takeshita K; Suda W; Mimura M; Hattori M; Kanai T
Digestion; 2017; 96(1):29-38. PubMed ID: 28628918
[TBL] [Abstract][Full Text] [Related]
11. Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial.
Aroniadis OC; Brandt LJ; Oneto C; Feuerstadt P; Sherman A; Wolkoff AW; Kassam Z; Sadovsky RG; Elliott RJ; Budree S; Kim M; Keller MJ
Lancet Gastroenterol Hepatol; 2019 Sep; 4(9):675-685. PubMed ID: 31326345
[TBL] [Abstract][Full Text] [Related]
12. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
[No Abstract] [Full Text] [Related]
13. The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors.
Lin H; Guo Q; Wen Z; Tan S; Chen J; Lin L; Chen P; He J; Wen J; Chen Y
Microb Cell Fact; 2021 Dec; 20(1):233. PubMed ID: 34963452
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Allogenic Versus Autologous Fecal Microbiota Transfer on Symptoms, Visceral Perception and Fecal and Mucosal Microbiota in Irritable Bowel Syndrome: A Randomized Controlled Study.
Holster S; Lindqvist CM; Repsilber D; Salonen A; de Vos WM; König J; Brummer RJ
Clin Transl Gastroenterol; 2019 Apr; 10(4):e00034. PubMed ID: 31009405
[TBL] [Abstract][Full Text] [Related]
15. An Open-Labeled Study on Fecal Microbiota Transfer in Irritable Bowel Syndrome Patients Reveals Improvement in Abdominal Pain Associated with the Relative Abundance of Akkermansia Muciniphila.
Cruz-Aguliar RM; Wantia N; Clavel T; Vehreschild MJGT; Buch T; Bajbouj M; Haller D; Busch D; Schmid RM; Stein-Thoeringer CK
Digestion; 2019; 100(2):127-138. PubMed ID: 30423561
[TBL] [Abstract][Full Text] [Related]
16. Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome.
Lahtinen P; Jalanka J; Hartikainen A; Mattila E; Hillilä M; Punkkinen J; Koskenpato J; Anttila VJ; Tillonen J; Satokari R; Arkkila P
Aliment Pharmacol Ther; 2020 Jun; 51(12):1321-1331. PubMed ID: 32343000
[TBL] [Abstract][Full Text] [Related]
17. Changes in colonic enteroendocrine cells of patients with irritable bowel syndrome following fecal microbiota transplantation.
Mazzawi T; Hausken T; El-Salhy M
Scand J Gastroenterol; 2022 Jul; 57(7):792-796. PubMed ID: 35156893
[TBL] [Abstract][Full Text] [Related]
18. Fecal microbiota transplantation for managing irritable bowel syndrome.
El-Salhy M; Mazzawi T
Expert Rev Gastroenterol Hepatol; 2018 May; 12(5):439-445. PubMed ID: 29493330
[TBL] [Abstract][Full Text] [Related]
19. Fecal microbiota transplantation for the treatment of irritable bowel syndrome: A systematic review and meta-analysis.
Halkjær SI; Lo B; Cold F; Højer Christensen A; Holster S; König J; Brummer RJ; Aroniadis OC; Lahtinen P; Holvoet T; Gluud LL; Petersen AM
World J Gastroenterol; 2023 May; 29(20):3185-3202. PubMed ID: 37346153
[TBL] [Abstract][Full Text] [Related]
20. Strain engraftment competition and functional augmentation in a multi-donor fecal microbiota transplantation trial for obesity.
Wilson BC; Vatanen T; Jayasinghe TN; Leong KSW; Derraik JGB; Albert BB; Chiavaroli V; Svirskis DM; Beck KL; Conlon CA; Jiang Y; Schierding W; Holland DJ; Cutfield WS; O'Sullivan JM
Microbiome; 2021 May; 9(1):107. PubMed ID: 33985595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
